Latest stories
-
Enoki Mushrooms and Cancer: What Mouse Studies and Nagano Data Really Show
Animal trials used purified extracts to boost immunity in mice, while a 1989 Japanese study linked lower cancer rates in farmers to…
-
Air Liquide Invests €170 Million to Support Japanese Semiconductor Manufacturer’s Expansion
TOKYO, September 30 — Air Liquide, the French multinational gas company, has announced a €170 million investment to supply ultra-high purity gases…
-
Eisai and Biogen Rework Aducanumab Deal as Lecanemab Partnership Continues Unchanged
TOKYO, July 14 — Eisai Co., Ltd., the Japanese pharmaceutical firm with a history in neurology, finds its Alzheimer’s strategy at a…
-
Antiques Roadshow Expert Theo Burrell Dies at 39 After Four-Year Brain Cancer Fight
LONDON, July 14 — Theo Burrell’s four-year battle with brain cancer ended at age 39, and her death has prompted renewed calls…
-
Experimental vaccine shields mice from fentanyl and its chemical relatives
WASHINGTON — Inside a laboratory, a small group of mice is changing how researchers think about the opioid crisis. These animals, immunized…
-
US Treasury Cuts Quarterly Borrowing Estimate by $76 Billion to $776 Billion
WASHINGTON, July 11 — The U.S. Treasury borrowed $776 billion in the first quarter of fiscal year 2024, a figure that underscores…
-
Reliance Unit Strand Life Sciences Wins Indian Patent for Blood-Based Cancer Detection
BENGALURU, July 7 — Strand Life Sciences, the genomic diagnostics subsidiary of Reliance Industries Limited, has secured an Indian patent for an…
-
Global Dietary Database Launched to Assess Food’s Health, Environmental, and Economic Impacts
LONDON, July 4 — A new global dietary database designed to support health, environmental and economic impact assessments has been developed by…
-
UK Phase 2 Trial Opens to Test CY-101 in Rare Adrenal Cancer
LONDON, July 5 — A new immunotherapy drug is entering clinical trials for patients with a rare and aggressive adrenal gland cancer…
-
ASIC Finds Six Super Platform Trustees Failing to Guard Members From Harmful Advice Fees
History keeps a file on financial watchdogs who bark and fail to bite. The Australian Securities and Investments Commission’s latest examination of…
-
Why Cross-Border Payments Remain Costly Despite Two Decades of Fintech
NEW YORK, July 1 — Obook Holdings Inc. (NASDAQ:OWLS) has announced a cross-border payment partnership through its OwlTing Group. The deal was…
-
Study: Quitting Smoking for Vaping Raises Lung Cancer Risk 56%
SEOUL — A sweeping new study out of South Korea is casting serious doubt on the idea that switching to e-cigarettes is…
-
Experts Say Bedtime Rituals Build Stronger Memories Than Grand Gestures
Forget the expensive birthday gift. Forget the family vacation. A child’s most vivid memory of a parent may come from five minutes…
-
Google Asks EPA for Permit to Release Up to 32 Million Lab-Bred Mosquitoes
SAN FRANCISCO, June 11 — A subsidiary of Google’s parent company has submitted a request to federal regulators for approval to deploy…
-
Breakthrough Imaging Reveals Cancer Immunotherapy Battlefield in Detail
For years, clinicians have faced a puzzling reality in cancer immunotherapy: a patient’s own immune system can sometimes eradicate a tumor, yet…
-
FDA Approves Moderna’s mNEXSPIKE COVID-19 Vaccine for Adults 65 and Older and High-Risk Teens
In May 2025, U.S. regulators granted approval to a revised formulation of the Moderna COVID‑19 vaccine, marketed as Mnexspike (mRNA‑1283). This authorization…
-
Cyclone Garance Kills Three After Landfall on Réunion Island
A powerful tropical cyclone named Garance made landfall in Réunion, a French island in the Indian Ocean, on February 28, 2025. Three…
-
FDA Approves Genentech’s Inavolisib for PIK3CA-Mutated Advanced Breast Cancer
On 15 October 2024, the U.S. Food and Drug Administration granted market authorization to Inavolisib, a novel therapy from Genentech, a Roche…
-
Dana-Farber Retracts and Corrects Dozens of Papers, Then CEO Laurie Glimcher Steps Down
BOSTON, USA — Dana-Farber Cancer Institute is facing a leadership crisis and a wave of scientific corrections after an investigation uncovered research…
-
Dengue Spreads Across Central America as Guatemala and Panama Report the Most Deaths
Health authorities in Latin America and the Caribbean are confronting an unprecedented dengue crisis, with 13 million suspected infections reported as of…
-
Enzalutamide Plus Hormone Therapy Cuts Death Risk 40.3% in Recurrent Prostate Cancer
In April 2023 the European Union authorized a fixed‑dose combination that merges two anticancer agents into a single tablet for the treatment…
-
FDA Grants Accelerated Approval to Elahere for FRalpha-Positive Platinum-Resistant Ovarian Cancer
The U.S. Food and Drug Administration granted approval on November 15, 2022, to Mirvetuximab soravtansine, a new medication marketed as Elahere, for…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992






















